UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2020

Commission File Number 1-14840

 

 

AMDOCS LIMITED

 

 

Hirzel House, Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F  ☒            FORM 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

YES  ☐            NO  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 


Submission of Matters to a Vote of Security Holders.

Voting Results.

At the 2020 Annual General Meeting of Shareholders of Amdocs Limited (the “Company”) held on January 31, 2020, the proposals listed below were submitted to a vote of the Company’s shareholders. The proposals are described in the Company’s proxy statement for the 2020 Annual General Meeting of Shareholders.

Proposal 1 – The election of ten nominees to the Company’s Board of Directors each for a term of one year.

The 10 nominees named in the proxy statement were elected to serve as directors until the Company’s 2021 Annual General Meeting of Shareholders. Information as to the vote on each director standing for election is provided below:

 

Nominee

   Votes For      Votes
Against
     Votes
Abstaining
     Broker
Non-Votes

Robert A. Minicucci

     108,505,003        9,037,035        425,149      —  

Adrian Gardner

     112,515,370        5,030,819        420,998      —  

James S. Kahan

     107,878,193        9,569,806        519,188      —  

Rafael de la Vega

     116,711,187        1,024,359        231,641      —  

Giora Yaron

     117,652,697        81,752        232,738      —  

Eli Gelman

     115,082,020        2,651,272        233,895      —  

Richard T.C. LeFave

     113,246,594        4,488,415        232,178      —  

John A. MacDonald

     117,509,641        226,044        231,502      —  

Shuky Sheffer

     117,085,889        645,982        235,316      —  

Yvette Kanouff

     117,694,550        44,912        227,725      —  

Proposal 2 – The approval of an amendment of the Amdocs Limited 1998 Stock Option and Incentive Plan increasing the number of shares authorized for issuance under the plan and the sublimit on “full value” awards under the plan, in each case, by 3,000,000 shares.

The shareholders approved an amendment of the Amdocs Limited 1998 Stock Option and Incentive Plan increasing the number of shares authorized for issuance under the plan and the sublimit on “full value” awards under the plan, in each case, by 3,000,000 shares. The voting results were as follows:

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes
103,494,815   9,219,083   5,253,289  

Proposal 3 – The approval of an increase in the dividend rate under the Company’s quarterly cash dividend program from $0.285 per share to $0.3275 per share.

The shareholders approved an increase in the dividend rate under the Company’s quarterly cash dividend program from $0.285 per share to $0.3275 per share. The voting results were as follows:

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes
117,760,194   5,242   201,751  

Proposal 4 – The approval of the Company’s Consolidated Financial Statements for the fiscal year ended September 30, 2019.

The shareholders approved the Company’s Consolidated Financial Statements for the fiscal year ended September 30, 2019. The voting results were as follows:

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes
117,357,838   1,551   607,798  


Proposal 5 – The ratification and approval of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2020, and until the next annual general meeting, and authorization of the Audit Committee of the Board of Directors to fix the remuneration of such independent registered public accounting firm in accordance with the nature and extent of its services.

The shareholders ratified and approved the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2020, and until the next annual general meeting, and authorized the Audit Committee of the Board of Directors to fix the remuneration of such independent registered public accounting firm in accordance with the nature and extent of its services. The voting results were as follows:

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes
113,107,129   4,641,869   218,189  


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

AMDOCS LIMITED
By:  

/s/ Matthew E. Smith

  Matthew E. Smith
  Secretary and Authorized Signatory

Date: February 3, 2020